The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Behavior Therapy

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Behavior Therapy


Psychiatry related information on Behavior Therapy


High impact information on Behavior Therapy


Chemical compound and disease context of Behavior Therapy


Biological context of Behavior Therapy


Anatomical context of Behavior Therapy


Gene context of Behavior Therapy


Analytical, diagnostic and therapeutic context of Behavior Therapy


  1. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. Berkowitz, R.I., Wadden, T.A., Tershakovec, A.M., Cronquist, J.L. JAMA (2003) [Pubmed]
  2. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Helmy, A. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  3. Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma. Pati, A.R., Godder, K.T., Abhyankar, S.H., Gee, A.P., Henslee-Downey, P.J. Bone Marrow Transplant. (1996) [Pubmed]
  4. Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin. Bornhäuser, M., Thiede, C., Schuler, U., Platzbecker, U., Freiberg-Richter, J., Helwig, A., Plettig, R., Röllig, C., Naumann, R., Kroschinsky, F., Neubauer, A., Ehninger, G. Bone Marrow Transplant. (2000) [Pubmed]
  5. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study. Vandereycken, W., Pierloot, R. Acta psychiatrica Scandinavica. (1982) [Pubmed]
  6. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. Anthonisen, N.R., Connett, J.E., Kiley, J.P., Altose, M.D., Bailey, W.C., Buist, A.S., Conway, W.A., Enright, P.L., Kanner, R.E., O'Hara, P. JAMA (1994) [Pubmed]
  7. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Carroll, K.M., Fenton, L.R., Ball, S.A., Nich, C., Frankforter, T.L., Shi, J., Rounsaville, B.J. Arch. Gen. Psychiatry (2004) [Pubmed]
  8. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. Henderson, D.C., Copeland, P.M., Daley, T.B., Borba, C.P., Cather, C., Nguyen, D.D., Louie, P.M., Evins, A.E., Freudenreich, O., Hayden, D., Goff, D.C. The American journal of psychiatry. (2005) [Pubmed]
  9. Optimal drug and behavior therapy for treatment-refractory schizophrenic patients. Liberman, R.P., Van Putten, T., Marshall, B.D., Mintz, J., Bowen, L., Kuehnel, T.G., Aravagiri, M., Marder, S.R. The American journal of psychiatry. (1994) [Pubmed]
  10. Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice. Ponnusamy, R., Nissim, H.A., Barad, M. Learn. Mem. (2005) [Pubmed]
  11. New treatments for smoking cessation. Hughes, J.R. CA: a cancer journal for clinicians. (2000) [Pubmed]
  12. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Schwartz, J.M., Stoessel, P.W., Baxter, L.R., Martin, K.M., Phelps, M.E. Arch. Gen. Psychiatry (1996) [Pubmed]
  13. Behavior therapy and pharmacotherapy for obesity. Craighead, L.W., Stunkard, A.J., O'Brien, R.M. Arch. Gen. Psychiatry (1981) [Pubmed]
  14. Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Morris, E., Thomson, K., Craddock, C., Mahendra, P., Milligan, D., Cook, G., Smith, G.M., Parker, A., Schey, S., Chopra, R., Hatton, C., Tighe, J., Hunter, A., Peggs, K., Linch, D., Goldstone, A., Mackinnon, S. Blood (2004) [Pubmed]
  15. Cyclophosphamide metabolism is affected by azole antifungals. Marr, K.A., Leisenring, W., Crippa, F., Slattery, J.T., Corey, L., Boeckh, M., McDonald, G.B. Blood (2004) [Pubmed]
  16. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission. Tiedemann, K., Waters, K.D., Tauro, G.P., Tucker, D., Ekert, H. Blood (1993) [Pubmed]
  17. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters. Marcus, M.D., Wing, R.R., Ewing, L., Kern, E., McDermott, M., Gooding, W. The American journal of psychiatry. (1990) [Pubmed]
  18. Use of the amobarbital interview to determine appropriate behavior therapy. Feldman, J., Meyding, G.F. The American journal of psychiatry. (1982) [Pubmed]
  19. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Nakao, T., Nakagawa, A., Yoshiura, T., Nakatani, E., Nabeyama, M., Yoshizato, C., Kudoh, A., Tada, K., Yoshioka, K., Kawamoto, M., Togao, O., Kanba, S. Biol. Psychiatry (2005) [Pubmed]
  20. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo. Weintraub, M., Sundaresan, P.R., Madan, M., Schuster, B., Balder, A., Lasagna, L., Cox, C. Clin. Pharmacol. Ther. (1992) [Pubmed]
  21. Phenelzine treatment of selective mutism in four prepubertal children. Golwyn, D.H., Sevlie, C.P. Journal of child and adolescent psychopharmacology. (1999) [Pubmed]
  22. The comparative effectiveness of treatments for obsessive-compulsive disorder. Greist, J.H. Bulletin of the Menninger Clinic. (1998) [Pubmed]
  23. Attitudes, beliefs, and practices regarding smoking and smoking cessation among African-American physicians and dentists. Hill, H.A., Braithwaite, R.L. Journal of the National Medical Association. (1997) [Pubmed]
  24. Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study. Andersson, B.S., Madden, T., Tran, H.T., Hu, W.W., Blume, K.G., Chow, D.S., Champlin, R.E., Vaughan, W.P. Biol. Blood Marrow Transplant. (2000) [Pubmed]
  25. High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation. Einsele, H., Ehninger, G., Schneider, E.M., Krüger, G.F., Vallbracht, A., Dopfer, R., Schmidt, H., Waller, H.D., Müller, C.A. Transplantation (1988) [Pubmed]
  26. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy. Pan, Y., Luo, B., Sozen, H., Kalscheuer, H., Blazar, B.R., Sutherland, D.E., Hering, B.J., Guo, Z. Transplantation (2003) [Pubmed]
  27. Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide as conditioning therapy. Mao, P., Wang, S., Wang, S., Zhu, Z., Liv, Q., Xuv, Y., Mo, W., Ying, Y. Bone Marrow Transplant. (2004) [Pubmed]
  28. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation. Testa, S., Manna, A., Porcellini, A., Maffi, F., Morstabilini, G., Denti, N., Macchi, S., Rosti, G., Porcellini, G., Cassi, D., Ferrari, L. Bone Marrow Transplant. (1996) [Pubmed]
  29. The effects of behavior modification vs lithium therapy on frontal lobe syndrome. Whaley, A.L., Stanford, C.B., Pollack, I.W., Lehrer, P.M. Journal of behavior therapy and experimental psychiatry. (1986) [Pubmed]
  30. The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation. Nordlander, A., Uzunel, M., Mattsson, J., Remberger, M. Br. J. Haematol. (2002) [Pubmed]
  31. Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma. Haas, R., Ehrhardt, R., Witt, B., Goldschmidt, H., Hohaus, S., Pförsich, M., Ehrlich, H., Färber, L., Hunstein, W. Bone Marrow Transplant. (1993) [Pubmed]
  32. Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients. Pihusch, M., Wegner, H., Goehring, P., Salat, C., Pihusch, V., Hiller, E., Andreesen, R., Kolb, H.J., Holler, E., Pihusch, R. Transplantation (2005) [Pubmed]
  33. Early drop in protein C and antithrombin III is a predictor for the development of venoocclusive disease in patients undergoing hematopoietic stem cell transplantation. Tabbara, I.A., Ghazal, C.D., Ghazal, H.H. Journal of hematotherapy. (1996) [Pubmed]
  34. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Jonas, C.R., Puckett, A.B., Jones, D.P., Griffith, D.P., Szeszycki, E.E., Bergman, G.F., Furr, C.E., Tyre, C., Carlson, J.L., Galloway, J.R., Blumberg, J.B., Ziegler, T.R. Am. J. Clin. Nutr. (2000) [Pubmed]
  35. Phenylpropanolamine OROS (Acutrim) vs. placebo in combination with caloric restriction and physician-managed behavior modification. Weintraub, M., Ginsberg, G., Stein, E.C., Sundaresan, P.R., Schuster, B., O'Connor, P., Byrne, L.M. Clin. Pharmacol. Ther. (1986) [Pubmed]
  36. The effect of oxybutynin treatment on cognition in children with diurnal incontinence. Sommer, B.R., O'Hara, R., Askari, N., Kraemer, H.C., Kennedy, W.A. J. Urol. (2005) [Pubmed]
  37. The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants. Walker, H., Singer, C.R., Patterson, J., Goldstone, A.H., Prentice, H.G. Br. J. Haematol. (1986) [Pubmed]
  38. Role of second bone marrow transplants. Shing, M.M., Vowels, M. Bone Marrow Transplant. (1993) [Pubmed]
WikiGenes - Universities